Spots Global Cancer Trial Database for high dose chemotherapy
Every month we try and update this database with for high dose chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy | NCT00205764 | Multiple Myelom... | Melphalan | 19 Years - 70 Years | Austrian Forum Against Cancer | |
| Total Skeletal Irradiation in Multiple Myeloma Before Second Autologous Hematopoietic Stem Cell Transplantation | NCT01182233 | Multiple Myelom... | Total Skeletal ... | 18 Years - 70 Years | University of Rochester | |
| Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation | NCT04691284 | Hematologic Neo... | Blood, urine an... | 18 Years - | National Cancer Institute, Slovakia | |
| Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma | NCT00577629 | Lymphoma, B-Cel... | cyclophosphamid... etoposide rituximab cytarabine doxorubicin tositumomab | 18 Years - | Duke University | |
| Phase III, Randomized Trial: Lenalidomide vs Observation After Induction With Rituximab Followed by Cht and ASCT in MCL Adult Patients | NCT02354313 | MANTLE CELL LYM... | Lenalidomide | 18 Years - 60 Years | Fondazione Italiana Linfomi - ETS | |
| Rituximab Maintenance After Autologous Transplantation | NCT01103388 | Non-Hodgkin's L... | Rituximab | - | M.D. Anderson Cancer Center | |
| BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT) | NCT02008006 | Follicular Lymp... | BeEAM | 18 Years - 65 Years | Centre Leon Berard | |
| BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT) | NCT02008006 | Follicular Lymp... | BeEAM | 18 Years - 65 Years | Centre Leon Berard | |
| Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma | NCT00577629 | Lymphoma, B-Cel... | cyclophosphamid... etoposide rituximab cytarabine doxorubicin tositumomab | 18 Years - | Duke University | |
| Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy | NCT00205764 | Multiple Myelom... | Melphalan | 19 Years - 70 Years | Austrian Forum Against Cancer | |
| Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma | NCT00577629 | Lymphoma, B-Cel... | cyclophosphamid... etoposide rituximab cytarabine doxorubicin tositumomab | 18 Years - | Duke University | |
| Total Skeletal Irradiation in Multiple Myeloma Before Second Autologous Hematopoietic Stem Cell Transplantation | NCT01182233 | Multiple Myelom... | Total Skeletal ... | 18 Years - 70 Years | University of Rochester | |
| Phase III, Randomized Trial: Lenalidomide vs Observation After Induction With Rituximab Followed by Cht and ASCT in MCL Adult Patients | NCT02354313 | MANTLE CELL LYM... | Lenalidomide | 18 Years - 60 Years | Fondazione Italiana Linfomi - ETS |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
